Status:
COMPLETED
Africa and Middle East Cardiovascular Epidemiological Study
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Obesity
Smoking
Eligibility:
All Genders
18+ years
Brief Summary
This is a cross-sectional, epidemiological study to determine the prevalence of cardiovascular risk factors such as obesity, smoking, dyslipidemia, diabetes mellitus and hypertension in patients atten...
Detailed Description
This is a cross-sectional, epidemiological study. In the course of this study, 4,300 persons from general practice, and other non specialist clinics of selected countries of the Africa and Middle East...
Eligibility Criteria
Inclusion
- Adult aged 18 or above
Exclusion
- Pregnant women and/or lactating mothers
- Subjects presenting with any life threatening disease/condition
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
4386 Patients enrolled
Trial Details
Trial ID
NCT01243138
Start Date
July 1 2011
End Date
April 1 2012
Last Update
February 18 2021
Active Locations (73)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Algiers, Algeria, 16015
2
Pfizer Investigational Site
Bejaja, Algeria, 6000
3
Pfizer Investigational Site
Djelfa, Algeria, 17000
4
Pfizer Investigational Site
Laghouat, Algeria